Singapore, March 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2, Randomized, Double-Masked, Placebo-Controlled, Multicenter Study to Assess the Safety, Pharmacokinetics, and Efficacy of AMG 732 in Healthy Subjects and Subjects with Moderate-to-Severe Active Thyroid Eye Disease'. The following are the other relevant details related to the trial:
Therapeutic Area: Ophthalmology
Trial Centre(s):
National University Hospital
Singapore National Eye Centre
Trial Status: Not Yet Recruiting
Principal Investigator(s):
Dr Blanche Lim
Dr Stephen G J Ng
Published by HT Digital Content Services with permission from Health Daily Digest....